Zika virus infection future or investigational therapies

Revision as of 21:10, 8 November 2016 by Nate Michalak (talk | contribs)
Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Zika virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Zika Virus Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Evaluation of Pregnant Women

Evaluation of Infants

Collection and Submission of Fetal Tissues

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Pregnant Women
Travel Notice
Blood Donation
Sexual transmission

Secondary Prevention

CDC Response Planning Tips

Risk-based Preparedness for States

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zika virus infection future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zika virus infection future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zika virus infection future or investigational therapies

CDC on Zika virus infection future or investigational therapies

Zika virus infection future or investigational therapies in the news

Blogs on Zika virus infection future or investigational therapies

Directions to Hospitals Treating Zika virus infection

Risk calculators and risk factors for Zika virus infection future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Nate Michalak, B.A.

Overview

There is currently no vaccine in advanced development to prevent Zika virus infection.

Future or Investigational Therapies

  • There is currently no vaccine in advanced development to prevent Zika virus infection.
  • It is unknown if vaccines against other flaviviruses are effective against Zika virus. The efficacy and safety of vaccines currently under development against Chikungunya virus are being studied in pre-clinical experiments for Zika virus.[2]
  • In February 2016, Sanofi, Pfizer, Johnson and Johnson, Merck,and Takeda announced the launching of projects to develop vaccines against Zika virus using either new technologies or existing vaccines.[3][4]
  • Recent animal studies have shown that human monoclonal antibodies against Zika virus envelope (E) protein, isolated from individuals with prior Zika virus infection, reduce tissue pathology, maternal-fetal transmission, and mortality when injected in mice.[1]

References

  1. Sapparapu G, Fernandez E, Kose N, Cao B, Fox JM, Bombardi RG; et al. (2016). "Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice". Nature. doi:10.1038/nature20564. PMID 27819683.